Niagen Bioscience (NAGE) Gains from Investment Securities (2010 - 2025)
Niagen Bioscience (NAGE) reported Gains from Investment Securities of $16000.0 for Q4 2025, down 80.25% year-over-year from $81000.0 in Q4 2024, and up 260.0% quarter-over-quarter from -$10000.0 in Q3 2025.
Niagen Bioscience (NAGE) Gains from Investment Securities (2010 - 2025) Analysis & Trends
Niagen Bioscience (NAGE) has 16 years of Gains from Investment Securities data on file, last reported at $16000.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $16000.0, down 80.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $16000.0 (up 33.33% YoY), and the FY2025 annual result was $12000.0, down 36.84% from the prior year.
- Gains from Investment Securities grew to $16000.0 in Q4 2025 per NAGE's latest filing, from -$10000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $81000.0 in Q4 2024 and troughed at -$135000.0 in Q4 2021.
- A 5-year average of -$6450.0 and a median of -$13000.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities tumbled 341.07% in 2021, then soared 1250.0% in 2022.
- A 5-year view of Gains from Investment Securities shows it stood at -$135000.0 in 2021, then jumped by 55.56% to -$60000.0 in 2022, then soared by 225.0% to $75000.0 in 2023, then gained by 8.0% to $81000.0 in 2024, then plunged by 80.25% to $16000.0 in 2025.
- Business Quant data shows NAGE's Gains from Investment Securities at $16000.0 in Q4 2025, -$10000.0 in Q3 2025, and $10000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Niagen Bioscience | 277.31 Mn | 210.76 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | 81,000.00 |
| Dec 31, 2024 | 81,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Sep 30, 2023 | -18,000.00 |